Summarizes data on the use of sedatives, including information about the effects on youth and older adults, legal status, costs and impact on health care.
This publication has been archived on the CCSA website and was current when it was published. It is available for reference or research purposes.
This alert summarizes the increased risk of accidental overdose due to nitazene compounds being identified in Canada’s unregulated drug supply. Nitazene compounds are ultra-high potency, synthetic opioids, usually found unexpectedly in substances…
Summarizes recommendations that emerged from a two-day meeting we hosted with national and international experts to identify a path toward implementing a standard THC unit in Canada. It also includes key actions and considerations in areas that…
Examines evidence about varying treatments for youth and older adults experiencing harms from prescription drug use in order to develop and implement effective care pathways.
Provides an overview of edible cannabis products, cannabis extracts and topical cannabis products. Outlines the differences among these products, including their use and effects.
Summarizes information on novel synthetic opioids that can appear in counterfeit pharmaceuticals and illicit street drugs. This bulletin defines novel synthetic opioids, such as fentanyl, and notes that the presence of these substances can…
This bulletin summarizes the risks and harms associated with nonmedical benzodiazepines and benzodiazepine-like substances that are increasingly being identified in drugs on the unregulated market, particularly drugs sold as opioids.…
Summarizes Canadian rates of calling 9-1-1 in drug poisoning situations, which greatly impacts the probability of surviving a drug-related overdose.
Provides the action plan for the Canadian Centre on Substance Use and Addiction (CCSA) for the years 2021 through 2026. The strategic plan presents the Centre’s three strategic priorities and two North Star outcomes. It also outlines the methods…
Summarizes the increased risk of accidental overdose due to xylazine in Canada’s unregulated drug supply. Xylazine is a non-opioid pain reliever developed as a sedative and muscle relaxant for animals. It is being found as an adulterant in other…
Summarizes information on the potential for serious adverse health consequences from using illicit fentanyl.
